History
Our Team
Research and Development
Dermatology and Aesthetics
Hematology
Hemoderivatives
Immunology and Transplantation
Nephrology
Neurology
Oncology
Over The Counter
All products
COPAXONE
Glatiramer Acetate
RENAGEL
Sevelamer Chlorhydrate
NOXPRIN
sodium enoxaparine
SUPRIMUN
Micophenolate mofetil
News
KIMATINIB LAUNCHING
Monday, July 27, 2009
Laboratorios Clausen SA announces the launch of Kimatinib (Imatinib Mesylate), produced at the plant in High Technology Clausen.
Launching of Interferon beta-1 a Clausen
Sunday, May 31, 2009
Laboratorios Clausen S.A announces the launching of Interferón beta-1a Clausen in prefilled syringes 6 and 12 MIU, indicated for the treatment of relapsing-remitting Multiple Sclerosis.
